Product Name | Forskolin |
Description |
Adenylate cyclase activator |
Purity | >99% |
CAS No. | 66575-29-9 |
Molecular Formula | C22H34O7 |
Molecular Weight | 410.51 |
Field of Use | Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only. |
Storage Temperature | -20ºC |
Shipping Temperature | Shipped Ambient |
Product Type | Activator |
Solubility | Soluble to 100 mM in DMSO, and to 10 mM in ethanol |
Source | Synthetic |
Appearance | White Solid |
SMILES | CC(=O)O[C@H]1[C@H]([C@@H]2[C@]([C@H](CCC2(C)C)O)([C@@]3([C@@]1(O[C@@](CC3=O)(C)C=C)C)O)C)O |
InChI | InChI=1S/C22H34O7/c1-8-19(5)11-14(25)22(27)20(6)13(24)9-10-18(3,4)16(20)15(26)17(28-12(2)23)21(22,7)29-19/h8,13,15-17,24,2 |
InChIKey | OHCQJHSOBUTRHG-KGGHGJDLSA-N |
Safety Phrases |
Classification: Caution: Substance not yet fully tested. Safety Phrases: S22 - Do not breathe dust S24/25 - Avoid contact with skin and eyes S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection Hazard Phrases: H312 Precautionary Phrases: P280 |
Cite This Product | Forskolin (StressMarq Biosciences, Canada, Cat # SIH-208) |
Alternative Names | (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-6,10,10b-Trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-3-vinyldodecahydro-1H-benzo[f]chromen-5-yl acetate |
Research Areas | Apoptosis, Cancer |
PubChem ID | 47936 |
Scientific Background | Forskolin resensitizes cell receptors by activating adenyl cyclase, and increasing the intracellular levels of cAMP (1). Medically forskolin provides a route to inhibition of colon cancer cell growth and survival (2). It is also a vasodilator, may be helpful in controlling the cause of glaucoma (3), reduces urinary tract infections, and may help to increase the skin's natural resistance to burning under UV light (1). |
References |
1. Passeron T., Namiki T., Passeron H.J., Le Pape E., and Hearing V.J. (2009) J Invest Dermatol. 129(1): 162-166. 2. McEwan D.G., Brunton V.G., Baillie G.S., Leslie N.R., Houslay M.D., and Frame M.C. (2007) Cancer Research. 67(11). 3. Pescosolido N., and Librando A. (2010) Clin Ter. 161(3): e81-5. |
Reviews
There are no reviews yet.